Therapeutic Targets Database
BIDD Pharmainformatics Databases


Target Validation Information
Target Name5-hydroxytryptamine 7 receptor    
Type of TargetResearch target    
Drug Potency against TargetSEROTONINIC50 = 1.5 nM[1]
WAY-208466IC50 = 4764 nM[4]
4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-oneKi < 1000 nM[5]
SB-269970Ki = 1.2 nM[6]
SB-269970Ki = 1.3 nM[7]
SPIPERONEKi = 110 nM[7]
5-chloro-4-methyl-3,4-dihydroquinazolin-2-amineKi = 15.9 nM[8]
2-(Biphenyl-2-yloxy)-N,N-dimethylethanamineKi = 156 nM[9]
DisulergineKi = 18 nM[7]
SB-656104Ki = 2 nM[7]
L-745870Ki = 226.3 nM[10]
SB-271046Ki = 260 nM[11]
2-(2-Bromophenoxy)-N,N-dimethylethanamineKi = 2663 nM[9]
5,6-dichloro-3,4-dihydroquinazolin-2-amineKi = 294 nM[8]
SB-258741Ki = 3 nM[7]
(R)-8-phenyl-N,N-dipropylchroman-3-amineKi = 3.38 nM[9]
SB-258719Ki = 32 nM[7]
WAY-466Ki = 329 nM[12]
2-(2-Bromophenylthio)-N,N-dimethylethanamineKi = 4110 nM[9]
2-(Biphenyl-2-ylthio)-N,N-dimethylethanamineKi = 553 nM[9]
(+/-)-nantenineKi = 67 nM[13]
WAY-181187Ki = 679 nM[14]
2-(2'-methyl-biphenyl-3-yl)-ethylamineKi = 7.5 nM[15]
N,N-dimethyl-2-(2'-methylbiphenyl-3-yl)ethanamineKi = 7.6 nM[9]
5-chloro-3,4-dihydroquinazolin-2-amineKi = 793 nM[8]
8-methoxy-4-methyl-3,4-dihydroquinazolin-2-amineKi = 8.2 nM[8]
1-Naphthalen-1-yl-piperazineKi = 83 nM[7]
UCM-5600Ki = 89 nM[2]
5-chloro-4-ethyl-3,4-dihydroquinazolin-2-amineKi = 97.4 nM[8]
Ref 1J Med Chem. 2008 Jul 24;51(14):4150-69. Epub 2008 Jun 28.Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity. To Reference
Ref 2J Med Chem. 2009 Apr 23;52(8):2384-92.Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity. To Reference
Ref 3Bioorg Med Chem. 2008 Mar 1;16(5):2570-8. Epub 2007 Nov 22.Novel quinazolinone derivatives as 5-HT7 receptor ligands. To Reference
Ref 4Bioorg Med Chem. 2009 Jul 15;17(14):5153-63. Epub 2009 May 29.Novel 1-aminoethyl-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines are potent 5-HT(6) agonists. To Reference
Ref 5J Med Chem. 2010 Sep 9;53(17):6386-97.Discovery of N-{1-[3-(3-oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential. To Reference
Ref 6Bioorg Med Chem Lett. 2009 Aug 15;19(16):4827-31. Epub 2009 Jun 13.Sulfonamides with the N-alkyl-N'-dialkylguanidine moiety as 5-HT7 receptor ligands. To Reference
Ref 7J Med Chem. 2003 Jul 3;46(14):2795-812.Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7). To Reference
Ref 8Bioorg Med Chem Lett. 2008 Jan 1;18(1):256-61. Epub 2007 Oct 30.Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: structure-activity relationship elucidation. To Reference
Ref 9Bioorg Med Chem. 2010 Mar 1;18(5):1958-67. Epub 2010 Jan 18.SAR studies on new bis-aryls 5-HT7 ligands: Synthesis and molecular modeling. To Reference
Ref 10Bioorg Med Chem Lett. 2001 Jun 4;11(11):1375-7.Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands. To Reference
Ref 11Bioorg Med Chem Lett. 2008 Jan 15;18(2):738-43. Epub 2007 Nov 17.Discovery of 3-aryl-3-methyl-1H-quinoline-2,4-diones as a new class of selective 5-HT6 receptor antagonists. To Reference
Ref 12J Med Chem. 2005 Jan 27;48(2):353-6.Discovery of 5-arylsulfonamido-3-(pyrrolidin-2-ylmethyl)-1H-indole derivatives as potent, selective 5-HT6 receptor agonists and antagonists. To Reference
Ref 13Bioorg Med Chem Lett. 2010 Jan 15;20(2):628-31. Epub 2009 Nov 20.Synthetic studies and pharmacological evaluations on the MDMA ('Ecstasy') antagonist nantenine. To Reference
Ref 14J Med Chem. 2007 Nov 15;50(23):5535-8. Epub 2007 Oct 19.Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonist. To Reference
Ref 15Bioorg Med Chem Lett. 2007 Jun 1;17(11):3018-22. Epub 2007 Mar 23.Novel aminoethylbiphenyls as 5-HT7 receptor ligands. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543